KLF6 and neoplasm: Again, tumor-derived KLF6 mutants fail to transactivate p21WAF1/CIP1, and to impede cell proliferation [67, 68], when wild type KLF6 induces apotosis in prostate cancer cells via the ATF3 transcription factor [69].